Home » Newsletters » BioWorld

BioWorld

March 10, 1993

View Archived Issues

MEDCHEM TO SPIN OFF SUBSIDIARY

OSTEX SUPPLIES BONE-LOSS TEST REAGENT

VICAL COMPLETES IPO

PERSEPTIVE COMPLETES OFFERING

MYCO RAISES $6 MILLION IN 1ST FINANCING ROUND

CANCER DRUG SHOWS EARLY EFFICACY

BIOSURFACE HALTS ONE OF ITS TRIALS

CORTECS SEEKS APPROVAL FOR TRIALS

BIOCYTE PATENT FOR USING PLACENTAS

ADVANCED POLYMER CHAIRMAN DIES

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.